An emerging body of research highlights plant-based vaccine manufacturing as a potential solution to risks posed by traditional egg-based manufacturing.
Researchers evaluated the risk of confounding bias in simulated test-negative studies that assessed estimated COVID-19 and influenza vaccine effectiveness.
Researchers conducted a study that compared early treatment with inhaled zanamivir vs oral oseltamivir on the risk for hospitalization or death due to influenza infection.
For children aged 5 to 17 years with asthma, quadrivalent live attenuated influenza vaccine (LAIV4) is noninferior to quadrivalent inactivated influenza vaccine (IIV4) for frequency of asthma exacerbations.
Researchers compared the incidence of intra-familial influenza transmission after treatment of the first family member with baloxavir marboxil vs oseltamivir.
Researchers examined the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine and a third dose of mRNA-1273 vaccine booster concomitantly.
During the 2021-2022 season, influenza vaccination did not reduce the risk for outpatient medically attended illness with influenza A(H3N2) viruses that have predominated this season.
Researchers conducted a study to compare hospitalizations due to COVID-19 infection plus multisystem inflammatory syndrome with those due to influenza and respiratory syncytial virus infection among children between 5 and 11 years.
Researchers conducted a study to determine whether homologous COVID-19 vaccination increases in vitro neutralizing activity against seasonal human coronaviruses.
Influenza vaccine effectiveness was 75% against life-threatening influenza in children during the 2019 to 2020 season, when vaccine-mismatched viruses predominated.
During a season predominated by 2 vaccine-mismatched viruses, vaccination was estimated to reduce the risk of life-threatening influenza illness by 75%.
This season’s flu vaccine may do little to prevent infection with the main circulating virus strain because the strain has changed since the vaccine was developed.
Researchers conducted a meta-analysis to determine the effectiveness of N95 respirators vs surgical masks in protecting against viral respiratory illness transmission.
Investigators conducted a study to assess the efficacy of a cell-based quadrivalent inactivated influenza vaccine (IIV4c) in preventing influenza virus infection in adolescents and children.